Exploring & exploiting our 'other self' - Does the microbiota hold the key to the future therapy in Crohn's?

Best Practice and Research: Clinical Gastroenterology

Volumn 28, Issue 3, 2014, Pages 399-409

  Haag, Lea Maxie ^a   Siegmund, Britta ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Crohn's disease; Inflammatory bowel disease; Microbiota; Prebiotics; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; MESALAZINE; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT;

ABDOMINAL ABSCESS; ANUS FISTULA; ARTICLE; BACTEROIDES; CROHN DISEASE; ENTEROCOCCUS; FAECALIBACTERIUM; FECES MICROFLORA; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LACTOBACILLUS; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS; PERIANAL ABSCESS; REGULATORY T LYMPHOCYTE; REMISSION; SACCHAROMYCES BOULARDII; STREPTOCOCCUS;

CROHN'S DISEASE; INFLAMMATORY BOWEL DISEASE; MICROBIOTA; PREBIOTICS; PROBIOTICS;

CROHN DISEASE; HUMANS; INTESTINAL MUCOSA; MICROBIOTA; PROBIOTICS;

EID: 84902262882     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2014.04.001     Document Type: Review

References (81)

1. C.A. Lozupone, J.I. Stombaugh, J.I. Gordon, J.K. Jansson, and R. Knight Diversity, stability and resilience of the human gut microbiota Nature 489 7415 2012 Sep 13 220 230
2. P.B. Eckburg, E.M. Bik, C.N. Bernstein, E. Purdom, L. Dethlefsen, and M. Sargent et al. Diversity of the human intestinal microbial flora Science 308 5728 2005 Jun 10 1635 1638
3. F. Fava, and S. Danese Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol 17 5 2011 Feb 7 557 566
4. K.J. Maloy, and F. Powrie Intestinal homeostasis and its breakdown in inflammatory bowel disease Nature 474 7351 2011 Jun 16 298 306
5. A. Izcue, J.L. Coombes, and F. Powrie Regulatory lymphocytes and intestinal inflammation Annu Rev Immunol 27 2009 313 338
6. D.N. Frank, A.L. St Amand, R.A. Feldman, E.C. Boedeker, N. Harpaz, and N.R. Pace Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases Proc Natl Acad Sci U S A 104 34 2007 Aug 21 13780 13785
7. P.B. Eckburg, and D.A. Relman The role of microbes in Crohn's disease Clin Infect Dis 44 2 2007 Jan 15 256 262
8. E.G. Zoetendal, A.D.L. Akkermans, W.M. Akkermans-van-Vliet, J.A.G.M. de Visser, and W.M. de Voss The host genotype affects the bacterial community in the human gastrointestinal tract Microb Ecol Health Dis 13 2001 129 134
9. S.R. Gill, M. Pop, R.T. Deboy, P.B. Eckburg, P.J. Turnbaugh, and B.S. Samuel et al. Metagenomic analysis of the human distal gut microbiome Science 312 5778 2006 Jun 2 1355 1359
10. F. Backhed, R.E. Ley, J.L. Sonnenburg, D.A. Peterson, and J.I. Gordon Host-bacterial mutualism in the human intestine Science 307 5717 2005 Mar 25 1915 1920
11. R. Thibault, F. Blachier, B. Darcy-Vrillon, P. de Coppet, A. Bourreille, and J.P. Segain Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency Inflamm Bowel Dis 16 4 2010 Apr 684 695
12. C. Cherbuy, B. Darcy-Vrillon, M.T. Morel, J.P. Pegorier, and P.H. Duee Effect of germfree state on the capacities of isolated rat colonocytes to metabolize n-butyrate, glucose, and glutamine Gastroenterology 109 6 1995 Dec 1890 1899
13. P.M. Smith, M.R. Howitt, N. Panikov, M. Michaud, C.A. Gallini, and Y.M. Bohlooly et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis Science 341 6145 2013 Aug 2 569 573
14. R.E. Ley, F. Backhed, P. Turnbaugh, C.A. Lozupone, R.D. Knight, and J.I. Gordon Obesity alters gut microbial ecology Proc Natl Acad Sci U S A 102 31 2005 Aug 2 11070 11075
15. A. Rehman, C. Sina, O. Gavrilova, R. Hasler, S. Ott, and J.F. Baines et al. Nod2 is essential for temporal development of intestinal microbial communities Gut 60 10 2011 Oct 1354 1362
16. A. Couturier-Maillard, T. Secher, A. Rehman, S. Normand, A. De Arcangelis, and R. Haesler et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer J Clin Invest 123 2 2013 Feb 1 700 711
17. J.L. Round, and S.K. Mazmanian The gut microbiota shapes intestinal immune responses during health and disease Nat Rev Immunol 9 5 2009 May 313 323
18. T. Olszak, D. An, S. Zeissig, M.P. Vera, J. Richter, and A. Franke et al. Microbial exposure during early life has persistent effects on natural killer T cell function Science 336 6080 2012 Apr 27 489 493
19. I. Ivanov, K. Atarashi, N. Manel, E.L. Brodie, T. Shima, and U. Karaoz et al. Induction of intestinal Th17 cells by segmented filamentous bacteria Cell 139 3 2009 Oct 30 485 498
20. S.J. Aujla, P.J. Dubin, and J.K. Kolls Th17 cells and mucosal host defense Semin Immunol 19 6 2007 Dec 377 382
21. E. Bettelli, T. Korn, and V.K. Kuchroo Th17: the third member of the effector T cell trilogy Curr Opin Immunol 19 6 2007 Dec 652 657
22. K. Atarashi, T. Tanoue, T. Shima, A. Imaoka, T. Kuwahara, and Y. Momose et al. Induction of colonic regulatory T cells by indigenous Clostridium species Science 331 6015 2011 Jan 21 337 341
23. K. Atarashi, T. Tanoue, K. Oshima, W. Suda, Y. Nagano, and H. Nishikawa et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota Nature 500 7461 2013 Aug 8 232 236
24. B. Sadlack, H. Merz, H. Schorle, A. Schimpl, A.C. Feller, and I. Horak Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene Cell 75 2 1993 Oct 22 253 261
25. R. Kuhn, J. Lohler, D. Rennick, K. Rajewsky, and W. Muller Interleukin-10-deficient mice develop chronic enterocolitis Cell 75 2 1993 Oct 22 263 274
26. P. Mombaerts, A.R. Clarke, M.A. Rudnicki, J. Iacomini, S. Itohara, and J.J. Lafaille et al. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages Nature 360 6401 1992 Nov 19 225 231
27. P. Rutgeerts, K. Goboes, M. Peeters, M. Hiele, F. Penninckx, and R. Aerts et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum Lancet 338 8770 1991 Sep 28 771 774
28. S.K. Mazmanian, C.H. Liu, A.O. Tzianabos, and D.L. Kasper An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system Cell 122 1 2005 Jul 15 107 118
29. H. Sokol, B. Pigneur, L. Watterlot, O. Lakhdari, L.G. Bermudez-Humaran, and J.J. Gratadoux et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients Proc Natl Acad Sci U S A 105 43 2008 Oct 28 16731 16736
30. H. Sokol, P. Seksik, J.P. Furet, O. Firmesse, I. Nion-Larmurier, and L. Beaugerie et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota Inflamm Bowel Dis 15 8 2009 Aug 1183 1189
31. M. Baumgart, B. Dogan, M. Rishniw, G. Weitzman, B. Bosworth, and R. Yantiss et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum ISME J 1 5 2007 Sep 403 418
32. B. Chassaing, and A. Darfeuille-Michaud The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases Gastroenterology 140 6 2011 May 1720 1728
33. M. Joossens, G. Huys, M. Cnockaert, V. De Preter, K. Verbeke, and P. Rutgeerts et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives Gut 60 5 2011 May 631 637
34. T.E. Adolph, M.F. Tomczak, L. Niederreiter, H.J. Ko, J. Bock, and E. Martinez-Naves et al. Paneth cells as a site of origin for intestinal inflammation Nature 503 7475 2013 Nov 14 272 276
35. A. Kaser, and R.S. Blumberg Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease Gastroenterology 140 6 2011 May 1738 1747
36. R. Rahimi, S. Nikfar, F. Rahimi, B. Elahi, S. Derakhshani, and M. Vafaie et al. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease Dig Dis Sci 53 9 2008 Sep 2524 2531
37. D. Haller, J.M. Antoine, S. Bengmark, P. Enck, G.T. Rijkers, and I. Lenoir-Wijnkoop Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome J Nutr 140 3 2010 Mar 690S 697S
38. A.L. Hart, K. Lammers, P. Brigidi, B. Vitali, F. Rizzello, and P. Gionchetti et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria Gut 53 11 2004 Nov 1602 1609
39. T. von der Weid, C. Bulliard, and E.J. Schiffrin Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10 Clin Diagn Lab Immunol 8 4 2001 Jul 695 701
40. K. Madsen, A. Cornish, P. Soper, C. McKaigney, H. Jijon, and C. Yachimec et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function Gastroenterology 121 3 2001 Sep 580 591
41. H. Jijon, J. Backer, H. Diaz, H. Yeung, D. Thiel, and C. McKaigney et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function Gastroenterology 126 5 2004 May 1358 1373
42. G. Hoermannsperger, T. Clavel, M. Hoffmann, C. Reiff, D. Kelly, and G. Loh et al. Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation PloS one 4 2 2009 e4365
43. N. Kamada, N. Inoue, T. Hisamatsu, S. Okamoto, K. Matsuoka, and T. Sato et al. Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis Inflamm Bowel Dis 11 5 2005 May 455 463
44. K.L. Madsen, J.S. Doyle, L.D. Jewell, M.M. Tavernini, and R.N. Fedorak Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice Gastroenterology 116 5 1999 May 1107 1114
45. M. Schultz, C. Veltkamp, L.A. Dieleman, W.B. Grenther, P.B. Wyrick, and S.L. Tonkonogy et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice Inflamm Bowel Dis 8 2 2002 Mar 71 80
46. C. Di Giacinto, M. Marinaro, M. Sanchez, W. Strober, and M. Boirivant Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells J Immunol 174 6 2005 Mar 15 3237 3246
47. L. Peran, S. Sierra, M. Comalada, F. Lara-Villoslada, E. Bailon, and A. Nieto et al. A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis Br J Nutr 97 1 2007 Jan 96 103
48. B. Foligne, S. Nutten, C. Grangette, V. Dennin, D. Goudercourt, and S. Poiret et al. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria World J Gastroenterol 13 2 2007 Jan 14 236 243
49. A. Grabig, D. Paclik, C. Guzy, A. Dankof, D.C. Baumgart, and J. Erckenbrecht et al. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways Infect Immun 74 7 2006 Jul 4075 4082
50. S.N. Ukena, A. Singh, U. Dringenberg, R. Engelhardt, U. Seidler, and W. Hansen et al. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity PloS One 2 12 2007 e1308
51. C. O'Mahony, P. Scully, D. O'Mahony, S. Murphy, F. O'Brien, and A. Lyons et al. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation PLoS Pathog 4 8 2008 e1000112
52. D. Jonkers, J. Penders, A. Masclee, and M. Pierik Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients Drugs 72 6 2012 Apr 16 803 823
53. W. Kruis, E. Schutz, P. Fric, B. Fixa, G. Judmaier, and M. Stolte Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis Aliment Pharmacol Ther 11 5 1997 Oct 853 858
54. W. Kruis, P. Fric, J. Pokrotnieks, M. Lukas, B. Fixa, and M. Kascak et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine Gut 53 11 2004 Nov 1617 1623
55. B.J. Rembacken, A.M. Snelling, P.M. Hawkey, D.M. Chalmers, and A.T. Axon Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial Lancet 354 9179 1999 Aug 21 635 639
56. A. Dignass, J.O. Lindsay, A. Sturm, A. Windsor, J.F. Colombel, and M. Allez et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management J Crohn's Colitis 6 10 2012 Dec 991 1030
57. C. Hedin, K. Whelan, and J.O. Lindsay Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials Proc Nutr Soc 66 3 2007 Aug 307 315
58. P. Gupta, H. Andrew, B.S. Kirschner, and S. Guandalini Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study J Pediatr Gastroenterol Nutr 31 4 2000 Oct 453 457
59. M. Guslandi, G. Mezzi, M. Sorghi, and P.A. Testoni Saccharomyces boulardii in maintenance treatment of Crohn's disease Dig Dis Sci 45 7 2000 Jul 1462 1464
60. M. Campieri, F. Rizzello, A. Venturi, P. Gilberto, F. Ugolini, and U. Helwig et al. Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: a randomized controlled study vs mesalamine Gastroenterology 118 2000 G4179
61. C. Prantera, M.L. Scribano, G. Falasco, A. Andreoli, and C. Luzi Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG Gut 51 3 2002 Sep 405 409
62. M. Schultz, A. Timmer, H.H. Herfarth, R.B. Sartor, J.A. Vanderhoof, and H.C. Rath Lactobacillus GG in inducing and maintaining remission of Crohn's disease BMC gastroenterol 4 2004 Mar 15 5
63. A. Bousvaros, S. Guandalini, R.N. Baldassano, C. Botelho, J. Evans, and G.D. Ferry et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease Inflamm Bowel Dis 11 9 2005 Sep 833 839
64. P. Marteau, M. Lemann, P. Seksik, D. Laharie, J.F. Colombel, and Y. Bouhnik et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial Gut 55 6 2006 Jun 842 847
65. A. Van Gossum, O. Dewit, E. Louis, G. de Hertogh, F. Baert, and F. Fontaine et al. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection Inflamm Bowel Dis 13 2 2007 Feb 135 142
66. H.A. Malchow Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? J Clin Gastroenterol 25 4 1997 Dec 653 658
67. A. Bourreille, G. Cadiot, G. Le Dreau, D. Laharie, L. Beaugerie, and J.L. Dupas et al. Saccharomyces boulardii does not prevent relapse of Crohn's disease Clin Gastroenterol Hepatol 11 8 2013 Aug 982 987
68. I. Koboziev, C. Reinoso Webb, K.L. Furr, and M.B. Grisham Role of the enteric microbiota in intestinal homeostasis and inflammation Free Radic Biol Med 68C 2013 Nov 22 122 133
69. S. Videla, J. Vilaseca, M. Antolin, A. Garcia-Lafuente, F. Guarner, and E. Crespo et al. Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat Am J Gastroenterol 96 5 2001 May 1486 1493
70. J. Winkler, R. Butler, and E. Symonds Fructo-oligosaccharide reduces inflammation in a dextran sodium sulphate mouse model of colitis Dig Dis Sci 52 1 2007 Jan 52 58
71. J.O. Lindsay, K. Whelan, A.J. Stagg, P. Gobin, H.O. Al-Hassi, and N. Rayment et al. Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease Gut 55 3 2006 Mar 348 355
72. J.L. Benjamin, C.R. Hedin, A. Koutsoumpas, S.C. Ng, N.E. McCarthy, and A.L. Hart et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease Gut 60 7 2011 Jul 923 929
73. H. Steed, G.T. Macfarlane, K.L. Blackett, B. Bahrami, N. Reynolds, and S.V. Walsh et al. Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease Aliment Pharmacol Ther 32 7 2010 Oct 872 883
74. S. Fujimori, A. Tatsuguchi, K. Gudis, T. Kishida, K. Mitsui, and A. Ehara et al. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease J Gastroenterol Hepatol 22 8 2007 Aug 1199 1204
75. I. Chermesh, A. Tamir, R. Reshef, Y. Chowers, A. Suissa, and D. Katz et al. Failure of synbiotic 2000 to prevent postoperative recurrence of Crohn's disease Dig Dis Sci 52 2 2007 Feb 385 389
76. A. Dignass, G. Van Assche, J.O. Lindsay, M. Lemann, J. Soderholm, and J.F. Colombel et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management J Crohns Colitis 4 1 2010 Feb 28 62
77. C. Prantera, H. Lochs, M. Campieri, M.L. Scribano, G.C. Sturniolo, and F. Castiglione et al. Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin Aliment Pharmacol Ther 23 8 2006 Apr 15 1117 1125
78. W. Selby, P. Pavli, B. Crotty, T. Florin, G. Radford-Smith, and P. Gibson et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease Gastroenterology 132 7 2007 Jun 2313 2319
79. E. van Nood, A. Vrieze, M. Nieuwdorp, S. Fuentes, E.G. Zoetendal, and W.M. de Vos et al. Duodenal infusion of donor feces for recurrent Clostridium difficile N Engl J Med 368 5 2013 Jan 31 407 415
80. T.J. Borody, and J. Campbell Fecal microbiota transplantation: current status and future directions Expert Rev Gastroenterol Hepatol 5 6 2011 Dec 653 655
81. J.L. Anderson, R.J. Edney, and K. Whelan Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease Aliment Pharmacol Ther 36 6 2012 Sep 503 516